AI assistant
Ipca Laboratories Ltd. — Call Transcript 2022
Nov 9, 2022
61700_rns_2022-11-09_913ff43d-b1cd-4523-a99c-b5f5b8961515.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [124 x 44] intentionally omitted <==
THRU ONLINE FILING
November 9, 2022
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494
National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB
Dear Sirs,
In accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the time of Conference Call to discuss the Company’s Q2FY23 earnings and business update has been rescheduled from 15.30 hrs IST to 16.30 hrs IST on Monday, 14[th] November, 2022.
Please find enclosed herewith the conference call / invite details.
This is for your information / record.
Thanking you
Yours faithfully For Ipca Laboratories Limited
Digitally signed by Harish Pandurang Kamath DN: c=IN, o=Personal, title=1715, pseudonym=3f7ac814d30fe4f87db4e251aafcbf81ab200 Harish Pandurang 03dc8e02a91eb3d7c33065f5b40, postalCode=400091, st=Maharashtra, Kamath serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, cn=Harish Pandurang Kamath Date: 2022.11.09 15:04:30 +05'30'
Harish P. Kamath Corporate Counsel & Company Secretary
Encl: a/a
lpca Laboratories Ltd. www.ipca.com
125, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T:+91 22 6210 5000 F:+91 22 62105005 Regd. Office:48, Kandivli Industrial Estate, Kandivli(West), Mumbai 400 067 (Maharashtra),India I T:+91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837
==> picture [124 x 44] intentionally omitted <==
REVISED INVITE FOR Q2FY23 EARNINGS CALL OF IPCA LABORATORIES LTD
MONDAY, 14[TH] NOVEMBER, 2022 AT 16.30 HRS IST
Mumbai, 9[th] November, 2022 : Ipca Laboratories Limited (BSE: 524494, NSE:IPCALAB) will organize a conference call for investors and analysts on Monday, 14[th] November, 2022 from 16.30 hrs to 17.30 hrs IST to discuss Q2FY23 earnings and business update. The conference call follows the announcement of the Company’s Q2FY23 financial results on Friday, 11[th] November, 2022.
Ipca Laboratories Limited management will be represented by Mr. A K Jain – Joint Managing Director and Mr. Harish Kamath – Corporate Counsel & Company Secretary.
The call will be hosted by Dam Capital Advisors Ltd..
Details of the conference call are as under:
Dial-in numbers
Universal Access: +044 7126 1302 +044 4563 4952 (accessible from all networks and countries)
Diamond Passcode link: https://registration.dsnl.in/2022/IPCA/index.php
International Dial-In
| Hong Kong | Singapore | UK | USA | |
|---|---|---|---|---|
| 19.00(HKT) | 19.00(SGT) | 12.00(BST) | 06.00(EDT) | |
| Toll | +852 3008 1599 | +65 3158 1878 | +44 20 3478 5527 | +1 212 994 0035 |
Please dial-in at least 5-10 minutes prior to the conference schedule to ensure that you are connected to the call in time.
For further information please contact
Anusha Kawthankar Nitin Agarwal Ipca Laboratories Limited Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) Tel : +91-22-6210 6051 Tel: +91-22-42022568 [email protected] [email protected]
lpca Laboratories Ltd.
125, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T:+91 22 6210 5000 F:+91 22 62105005 Regd. Office:48, Kandivli Industrial Estate, Kandivli(West), Mumbai 400 067 (Maharashtra),India I T:+91 22 6647 4444
E: [email protected] CIN: L24239MH1949PLC007837